Brevan Howard Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Brevan Howard Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,679	Closed	-$563K	–	2033
2025 Q3	$563K	Buy	+20,679	New	+$500K	﹤0.01%	1224
2025 Q2	–	Sell	-13,788	Closed	-$226K	–	1916
2025 Q1	$226K	Sell	13,788 -30,751	-69%	-$655K	﹤0.01%	941
2024 Q4	$1.14M	Buy	44,539 +30,213	+211%	+$855K	0.01%	397
2024 Q3	$454K	Buy	+14,326	New	+$543K	﹤0.01%	710

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Brevan Howard Capital Management's IDYA Position: Q4 2025 in Review

Brevan Howard Capital Management sold out of IDEAYA Biosciences (IDYA) in Q4 2025, closing a stake of 20,679 shares — an estimated $563K sold.

Brevan Howard Capital Management first reported a position in IDYA in Q3 2024 and held it in 4 quarters. The position peaked at $1.14M in Q4 2024. 246 funds tracked by Wall St. Rank hold IDYA as of Q4 2025.

Brevan Howard Capital Management reported no remaining IDEAYA Biosciences position as of Q4 2025 after selling out during the quarter.
Brevan Howard Capital Management sold 20,679 IDEAYA Biosciences shares in Q4 2025, an estimated $563K.
Brevan Howard Capital Management first reported a position in IDEAYA Biosciences in Q3 2024 and held it in 4 quarters.
Brevan Howard Capital Management's IDEAYA Biosciences position peaked at $1.14M in Q4 2024.
246 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2025.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.